documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
120 rows where docket_id = "FDA-1995-N-0063" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 5
- Supporting & Related Material 102
- Other 6
- Notice 4
- Proposed Rule 4
- Rule 4
agency_id 1
- FDA 120
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1995-N-0063-0147 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 60 Infant Formula Act of 1980 Report by the Committee on Labor and Human Resources United States Senate | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T14:40:06Z | 0 | 0 | 090000648172d7c7 | |||
| FDA-1995-N-0063-0145 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 57 Jensen and Jensen Invited Review Specialty Lipids for Infant Nutrition I. Milks and Formulas | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T14:36:38Z | 0 | 0 | 090000648172d7c4 | |||
| FDA-1995-N-0063-0169 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 81 Minton et al Bone Mineral Content in Term and Preterm Appropriate-for-Gestational-Age Infants | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:06:53Z | 0 | 0 | 090000648174e748 | |||
| FDA-1995-N-0063-0159 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 58 Ziegler et al Cow Milk Feeding in Infancy: Further Observations on Blood Loss from the Gastrointestinal Tract | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:54:21Z | 0 | 0 | 090000648172d7c5 | |||
| FDA-1995-N-0063-0140 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 52 Summary of Findings | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T14:31:12Z | 0 | 0 | 090000648172d7b5 | |||
| FDA-1995-N-0063-0155 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 69 Shenai et al Nutritional Balance Studies in Very Low-Birth- Weight Infants: Role of Soy Formula | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:47:32Z | 0 | 0 | 090000648172de15 | |||
| FDA-1995-N-0063-0156 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 70 Lindroth et al Rickets in Very Low Birthweight Infants | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:48:27Z | 0 | 0 | 090000648172de16 | |||
| FDA-1995-N-0063-0176 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 88 Memorandum of Telephone Conversation between Ed puro, FDA, and Mary Hudtloff Dated March 15, 1994 | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:11:06Z | 0 | 0 | 090000648174e74f | |||
| FDA-1995-N-0063-0160 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 66 Koletzko et al Intestinal Milk - Bolus Obstruction in Formula-Fed Premature Infants Given High Doses of Calcium | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:54:29Z | 0 | 0 | 090000648172de12 | |||
| FDA-1995-N-0063-0158 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 72 FDA Guideline for the Format and Content of the Clinical and Statistical Sections of New Drug Applications | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:50:34Z | 0 | 0 | 090000648172de18 | |||
| FDA-1995-N-0063-0146 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 59 Committee on Nutrition Commentary on Breast-Feeding and Infant Formulas, Including Proposed Standards for Formulas | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T14:38:37Z | 0 | 0 | 090000648172d7c6 | |||
| FDA-1995-N-0063-0168 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 80 Ryan et al Phosphate, Alkaline Phosphatase and Bone Mineralization in Preterm Neonates | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:06:09Z | 0 | 0 | 090000648174e747 | |||
| FDA-1995-N-0063-0151 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 64 Samuel J. Fomon, M.D. Nutrition of Normal Infants | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:36:36Z | 0 | 0 | 090000648172de10 | |||
| FDA-1995-N-0063-0166 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 75 Moore and Roche Pediatric Anthropometry 2nd Edition | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:02:05Z | 0 | 0 | 090000648174e567 | |||
| FDA-1995-N-0063-0163 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 77 Sarwar et al Difference in Protein Digestibility and Quality of Liquid Concentrate and Powder Forms of Milk-Baed Infant Formulas Fed to Rats | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:59:42Z | 0 | 0 | 090000648174e744 | |||
| FDA-1995-N-0063-0165 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 79 Fomon and Nelson Calcium, Phoshorus, Magnesium, and Sulfur | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:01:39Z | 0 | 0 | 090000648174e746 | |||
| FDA-1995-N-0063-0177 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 89 Memorandum of Telephone Conversation between Ed Puro, FDA, and Lorena, Hazleton Labs Dated March 17, 1993 | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:11:35Z | 0 | 0 | 090000648174e750 | |||
| FDA-1995-N-0063-0144 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 56 Jensen et al Lipids of Human Milk and Infant Formulas: A Review | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T14:35:40Z | 0 | 0 | 090000648172d7c3 | |||
| FDA-1995-N-0063-0141 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 53 Internal FDA Memo dated May 12, 1994 | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T14:32:07Z | 0 | 0 | 090000648172d7b6 | |||
| FDA-1995-N-0063-0149 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 62 Hallberg et al Bioavailability in Man of Iro in Human Milk and Cow's Milk in Relation to Their Calcium Contents | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:35:08Z | 0 | 0 | 090000648172d3be | |||
| FDA-1995-N-0063-0154 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 68 Moya et al Short-Term polcose Substitution for Lactose Reduces Calcium Absorption in Healthy Term Babies | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:46:45Z | 0 | 0 | 090000648172de14 | |||
| FDA-1995-N-0063-0171 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 83 Gary M. Chan Performance of Dual Energy X-Ray Absorptiometry in Evaluatiing Bone, Lean Body Mass, and Fat in Pediatric Subjects | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:07:57Z | 0 | 0 | 090000648174e74a | |||
| FDA-1995-N-0063-0172 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 84 Braillon et al Dual energy X-Ray Absorptiometry Measurements of bone mineral Content in Newborns: Validation of the Technique | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:08:29Z | 0 | 0 | 090000648174e74b | |||
| FDA-1995-N-0063-0173 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 85 Salle and Glorieux Assessment of Bone Mineral Content in Infants: The New Age | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:08:59Z | 0 | 0 | 090000648174e74c | |||
| FDA-1995-N-0063-0174 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 86 Samuel J. Fomon Nutrition of Normal Infants | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:09:38Z | 0 | 0 | 090000648174e74d | |||
| FDA-1995-N-0063-0157 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 71 Chan and Mileur Posthospitalization Growth and Bone Mineral Status of Normal Preterm Infants | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:49:19Z | 0 | 0 | 090000648172de17 | |||
| FDA-1995-N-0063-0142 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 54 Tanner et al Analysis of Milk-Based Infant Formula | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T14:33:22Z | 0 | 0 | 090000648172d7c0 | |||
| FDA-1995-N-0063-0162 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 74 Roche et al Weight and Recumbent Lenght from 1 to 12 Mo of Age: Refenece DAta for 1-mo Increments | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:56:14Z | 0 | 0 | 090000648174e566 | |||
| FDA-1995-N-0063-0167 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 76 Behrman et al Nelson Textbook of Pediatrics 14th Edition | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:02:12Z | 0 | 0 | 090000648174e568 | |||
| FDA-1995-N-0063-0164 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 78 Rudloff and Lonnerdal Solubility and Digestibility of Milk Proteins in Infant Formmulas Exposed to Different Heat Treatments | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:00:32Z | 0 | 0 | 090000648174e745 | |||
| FDA-1995-N-0063-0170 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 82 Steichen et al Bone Mineral Content Measurement in Small Infants by Single-Photon Absorptiometry: Cureent Methodologic Issues | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:07:24Z | 0 | 0 | 090000648174e749 | |||
| FDA-1995-N-0063-0148 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 61 Saarinen et al Iron Absorption in Infants: High Bioavailability of Breast milk Iron as Indicated by the Extrinsic Tag Method of Iron Absorption and by the Concentration of Serum Ferritin | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:25:25Z | 0 | 0 | 090000648172d3bd | |||
| FDA-1995-N-0063-0150 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 63 Derman et al Factors Influencing the Absorption of Iron from Soya-Bean Protein Products | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:35:46Z | 0 | 0 | 090000648172de0f | |||
| FDA-1995-N-0063-0161 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 73 Lewis A. Barness Pediatric Nutrition Handbook 3rd Edition | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:55:22Z | 0 | 0 | 090000648174e565 | |||
| FDA-1995-N-0063-0152 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 65 Steichen et al Osteopenia of Prematurity: The Cause and Possible Treatment | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:44:26Z | 0 | 0 | 090000648172de11 | |||
| FDA-1995-N-0063-0178 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 90 Incorporated by Reference to Federal Register Notice Published July 9, 1996 | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:12:36Z | 0 | 0 | 090000648174e751 | |||
| FDA-1995-N-0063-0153 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 67 Ziegler and Fomon Lactose Enhances Mineral Absorption in Infancy | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T15:46:01Z | 0 | 0 | 090000648172de13 | |||
| FDA-1995-N-0063-0175 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 87 Carlson et al First Year Growth of Preterm Infants Fed Standard Compared to Marine Oil n-3 Supplemented Formula | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T16:10:19Z | 0 | 0 | 090000648174e74e | |||
| FDA-1995-N-0063-0143 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 55 Southgate et al Nutrient Availability: Chemical and Biological Aspects | Supporting & Related Material | Background Material | 2014-07-17T04:00:00Z | 2014 | 7 | 2014-07-17T14:34:10Z | 0 | 0 | 090000648172d7c2 | |||
| FDA-1995-N-0063-0100 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment C Industry Proposal on Infant Formula Powder Labeling Comment International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:08:04Z | 0 | 0 | 090000648056cb93 | |||
| FDA-1995-N-0063-0089 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment A Suggested Language Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:04:32Z | 0 | 0 | 090000648056cb68 | |||
| FDA-1995-N-0063-0096 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment on Basis and Context of Sample Growth Trial Protocol Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:06:25Z | 0 | 0 | 090000648056cb75 | |||
| FDA-1995-N-0063-0114 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 26 No Material Submitted | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:24:11Z | 0 | 0 | 090000648172d766 | |||
| FDA-1995-N-0063-0117 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 29 Ronald F Tetzlaff GMP Documentation Requirements for Automated Systems Part 1 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:25:23Z | 0 | 0 | 090000648172d769 | |||
| FDA-1995-N-0063-0121 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 33 Salmonella Ealing Inspections Associated with Consumption of Infant Dired Milk | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:27:41Z | 0 | 0 | 090000648172d770 | |||
| FDA-1995-N-0063-0133 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 45 Jackson et al Control of Salmonellosis and Similar Foodborne Infections | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:38:31Z | 0 | 0 | 090000648172d7aa | |||
| FDA-1995-N-0063-0115 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 27 IEEE Standard Glossary of Software Engineering Terminology | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:24:39Z | 0 | 0 | 090000648172d767 | |||
| FDA-1995-N-0063-0125 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 37 Farber and Peterkin Listeria Monocytogenes A Food Borne Pathogen | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:33:51Z | 0 | 0 | 090000648172d7a2 | |||
| FDA-1995-N-0063-0119 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 31 Ronald F Tetzlaff GMP Documentation Requirements for Automated Systems Part 3, FDA Inspections of Computerized Laboratory Systems | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:26:09Z | 0 | 0 | 090000648172d76e | |||
| FDA-1995-N-0063-0093 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment E Letter from IFC to FDA CFSAN dated July 7 2003 Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:05:35Z | 0 | 0 | 090000648056cb6f | |||
| FDA-1995-N-0063-0103 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment F Letter from Douglas L Archer to International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:03:17Z | 0 | 0 | 090000648056cb8b | |||
| FDA-1995-N-0063-0086 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Withdrawal of Comments from International Formula Council | Other | Withdrawal | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T04:00:00Z | 2014-07-17T16:30:30Z | 0 | 0 | 090000648056cbd3 | ||
| FDA-1995-N-0063-0095 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment G Guidelines Concerning Notification and Testing of Infant Formulas Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:06:06Z | 0 | 0 | 090000648056cb73 | |||
| FDA-1995-N-0063-0107 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Appendix A3 Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:14:16Z | 0 | 0 | 090000648056cc22 | |||
| FDA-1995-N-0063-0136 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 48 Harmon and Kautter Incidence and Growth Potential of Bacillus cerues in Ready-to Serve Foods | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:46:11Z | 0 | 0 | 090000648172d7af | |||
| FDA-1995-N-0063-0124 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 36 Paul G. Quie Antimicrobial Defenses in the Neonante | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:33:28Z | 0 | 0 | 090000648172d773 | |||
| FDA-1995-N-0063-0127 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 39 Abram S. Benenson Control of Communicable Diseases in Man | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:34:37Z | 0 | 0 | 090000648172d7a4 | |||
| FDA-1995-N-0063-0135 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 47 Robert T. Marshall Standard Methods for the Examination of Dairy Products | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:45:36Z | 0 | 0 | 090000648172d7ae | |||
| FDA-1995-N-0063-0134 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 46 FDA Bacteriological Analytical Manual 7th Edition 1992 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:45:18Z | 0 | 0 | 090000648172d7ad | |||
| FDA-1995-N-0063-0091 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment C Industry Proposal on Infant Formula Powder Labeling Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:05:02Z | 0 | 0 | 090000648056cb6c | |||
| FDA-1995-N-0063-0098 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment A International Formula Council Suggested Language Comment International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:06:58Z | 0 | 0 | 090000648056cb97 | |||
| FDA-1995-N-0063-0094 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment F Letter from Douglas L Archer to IFC Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:05:51Z | 0 | 0 | 090000648056cb71 | |||
| FDA-1995-N-0063-0109 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 6 American Academy of Pediatrics Clinical Testing of Infant Formulas with Respect to Nutritional Suitability for Team Infants | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:20:33Z | 0 | 0 | 090000648172d722 | |||
| FDA-1995-N-0063-0120 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 32 Letter from Infant Formula Council to FDA Dated March 31, 1993 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:26:48Z | 0 | 0 | 090000648172d76f | |||
| FDA-1995-N-0063-0122 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 34 Letter from Infant Formula Council to FDA Dated June 24, 1993 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:28:24Z | 0 | 0 | 090000648172d771 | |||
| FDA-1995-N-0063-0137 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 49 FDA / CFSAN Draft of Microbiological Evaulation of Powdered Infant Formula Prepared by David A. Golden, Ph.D. | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:46:51Z | 0 | 0 | 090000648172d7b2 | |||
| FDA-1995-N-0063-0112 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 9 Infant Formula Council Recommended Current Good Manufacturing Practice for Infant Formula | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:22:32Z | 0 | 0 | 090000648172d725 | |||
| FDA-1995-N-0063-0113 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 25 Guidelines on Sterile Drug Products Produced by Aseptic Processing dated June 1987 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:23:30Z | 0 | 0 | 090000648172d765 | |||
| FDA-1995-N-0063-0123 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 35 Michael P. Doyle Foodborne Bacterial Pathogens | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:33:04Z | 0 | 0 | 090000648172d772 | |||
| FDA-1995-N-0063-0126 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 38 Listeria Monocytogenes Recommendations by the National Advisory Committee on Microbiological criteria for Foods | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:34:15Z | 0 | 0 | 090000648172d7a3 | |||
| FDA-1995-N-0063-0128 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 40 Balows et al Laboratory Diagnosis of Infectious Diseases Principles and Pratice Volume 1 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:34:59Z | 0 | 0 | 090000648172d7a5 | |||
| FDA-1995-N-0063-0130 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 42 Schwab et al Microbiological Quality of Dry-Milk Mixes and Milk Substitute Infant Formulas | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:37:26Z | 0 | 0 | 090000648172d7a7 | |||
| FDA-1995-N-0063-0092 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment D Proposed Discussion Points on Powdered Infant Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:05:21Z | 0 | 0 | 090000648056cb6e | |||
| FDA-1995-N-0063-0105 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Appendix A1 Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:12:53Z | 0 | 0 | 090000648056cc19 | |||
| FDA-1995-N-0063-0108 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Appendix B Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:15:56Z | 0 | 0 | 090000648056cc1c | |||
| FDA-1995-N-0063-0085 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Correction from International Formula Council | Other | Correction(s) | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T04:00:00Z | 2014-07-16T13:57:23Z | 0 | 0 | 090000648056cbcd | ||
| FDA-1995-N-0063-0090 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment B FDA Infant Formula GMP Regulation Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:04:48Z | 0 | 0 | 090000648056cb6a | |||
| FDA-1995-N-0063-0102 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment E Letter from IFC to FDA/CFSAN dated July 7 2003 Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:01:32Z | 0 | 0 | 090000648056cb90 | |||
| FDA-1995-N-0063-0097 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment L Decision Tree Chart for Documentation of Nutritional Adequacy of a New or Changed Infant Formula Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:06:39Z | 0 | 0 | 090000648056cb79 | |||
| FDA-1995-N-0063-0106 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Appendix A2 Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:12:14Z | 0 | 0 | 090000648056cc1b | |||
| FDA-1995-N-0063-0129 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 41 Chapter 2 Microorganisms in Foods | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:35:21Z | 0 | 0 | 090000648172d7a6 | |||
| FDA-1995-N-0063-0131 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 43 Collins-Thompson et al Microbiological Guidelines and Sampling Plans for Dried Infant Cereals and Powdered Infant Formula from a Canadian National Microbiological Survey | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:37:47Z | 0 | 0 | 090000648172d7a8 | |||
| FDA-1995-N-0063-0104 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment L Decision Tree Chart for Documentation of Nutritional Adequacy of a New or Changed Infant Formula Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:03:51Z | 0 | 0 | 090000648056cb9d | |||
| FDA-1995-N-0063-0110 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 7 Congressional Record House Vol 126 Dated May 20, 1980 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:21:12Z | 0 | 0 | 090000648172d723 | |||
| FDA-1995-N-0063-0111 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 8 Guidelines Concerning Notification and Testing of Infant Formulas | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:21:54Z | 0 | 0 | 090000648172d724 | |||
| FDA-1995-N-0063-0116 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 28 FDA Glossary of Computerized System and Software Development Terminology August 1995 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:25:05Z | 0 | 0 | 090000648172d768 | |||
| FDA-1995-N-0063-0118 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 30 Ronald F Tetzlaff GMP Documentation Requirements for Automated Systems Part 2 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:25:47Z | 0 | 0 | 090000648172d76a | |||
| FDA-1995-N-0063-0101 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment D Proposed Discussion Points on Powdered Infant Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:08:23Z | 0 | 0 | 090000648056cb91 | |||
| FDA-1995-N-0063-0099 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Attachment B FDA Infant Formula GMP Regulation Comment from International Formula Council | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:07:48Z | 0 | 0 | 090000648056cb9f | |||
| FDA-1995-N-0063-0132 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 44 FDA Enforcement Report dated July, 14 1993 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:38:07Z | 0 | 0 | 090000648172d7a9 | |||
| FDA-1995-N-0063-0138 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 50 FDA Consumer October 1988 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:47:21Z | 0 | 0 | 090000648172d7b3 | |||
| FDA-1995-N-0063-0139 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 51 Memorandum of Record dated June 25, 1996 | Supporting & Related Material | Background Material | 2014-07-16T04:00:00Z | 2014 | 7 | 2014-07-16T16:47:48Z | 0 | 0 | 090000648172d7b4 | |||
| FDA-1995-N-0063-0077 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula; Correction | Rule | Correction | 2014-07-15T04:00:00Z | 2014 | 7 | 2014-07-15T04:00:00Z | 2014-07-15T14:43:19Z | 2014-16476 | 0 | 0 | 09000064817ad884 | |
| FDA-1995-N-0063-0061 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Comment from Jason and Jarvis Associates, LLC re FDA-1995-N-0063-0058 | Supporting & Related Material | Background Material | 2014-07-09T04:00:00Z | 2014 | 7 | 2014-07-09T15:32:46Z | 0 | 0 | 090000648167063e | |||
| FDA-1995-N-0063-0051 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 1 - FDA. Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula. Regulatory Impact Analysis for Final Rule - Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula | Supporting & Related Material | Background Material | 2014-06-10T04:00:00Z | 2014 | 6 | 2014-06-10T20:26:38Z | 0 | 0 | 09000064817368eb | |||
| FDA-1995-N-0063-0052 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference - 1-1 Zink, Don. Statement of Donald L. Zink, Ph. D.: Infant Formula Manufacturing Practices, 2013 - Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula | Supporting & Related Material | Background Material | 2014-06-10T04:00:00Z | 2014 | 6 | 2014-06-10T20:26:49Z | 0 | 0 | 09000064817368ed | |||
| FDA-1995-N-0063-0050 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | List of References | Supporting & Related Material | Background Material | 2014-06-10T04:00:00Z | 2014 | 6 | 2014-06-10T19:00:18Z | 0 | 0 | 09000064817368ec | |||
| FDA-1995-N-0063-0053 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 1-2 - Silverman, B. Statement of Benson M. Silverman, M.D. "Industry Efforts to Meet Quality Factor Requirements," 2013 - Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula | Supporting & Related Material | Background Material | 2014-06-10T04:00:00Z | 2014 | 6 | 2014-06-10T20:27:04Z | 0 | 0 | 09000064817368ee | |||
| FDA-1995-N-0063-0054 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Reference 1-3 - Dickinson, D.L. and R.L. Verbeek. "Wage Differentials Between College Graduates With and Without Learning Disabilities - Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula | Supporting & Related Material | Background Material | 2014-06-10T04:00:00Z | 2014 | 6 | 2014-06-10T20:27:20Z | 0 | 0 | 09000064817368ef | |||
| FDA-1995-N-0063-0049 | FDA | CGMPs for the Production of Infant Formula FDA-1995-N-0063 | Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula | Rule | Final Rule | 2014-06-10T04:00:00Z | 2014 | 6 | 2014-06-10T04:00:00Z | 2014-07-11T03:59:59Z | 2014-07-03T01:01:55Z | 2014-13384 | 0 | 0 | 0900006481734cd4 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);